Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 164.695
-0.372 %
$ 8.42 B
Market Cap
823.47
P/E
Price Target
Average
43.70%
Revenue Forecast
Estimate
4.59%
EBIT
Estimate
17.50%
Net Income
Estimate
220.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Charles River Laboratories International, Inc.
Wall Street analysts predict an average 1-year price target for CRL of $237 , with forecasts ranging from
a
low of
$151 to a high of $300 .
CRL Lowest Price Target
Wall Street Target
151 USD
-8.32%
CRL Average Price Target
Wall Street Target
237 USD
43.70%
CRL Highest Price Target
Wall Street Target
300 USD
82.15%
REVENUE FORECAST
Revenue Forecast Chart CRL
EBIT FORECAST
EBIT Forecast Chart CRL
NET INCOME FORECAST
Net Income Chart CRL